2020
Behavioral Problems at Age 11 Years After Prenatal and Postnatal Exposure to Acetaminophen: Parent-Reported and Self-Reported Outcomes
Inoue K, Ritz B, Ernst A, Tseng WL, Yuan Y, Meng Q, Ramlau-Hansen CH, Strandberg-Larsen K, Arah OA, Obel C, Li J, Olsen J, Liew Z. Behavioral Problems at Age 11 Years After Prenatal and Postnatal Exposure to Acetaminophen: Parent-Reported and Self-Reported Outcomes. American Journal Of Epidemiology 2020, 190: 1009-1020. PMID: 33230558, PMCID: PMC8248972, DOI: 10.1093/aje/kwaa257.Peer-Reviewed Original ResearchConceptsPrenatal acetaminophen exposurePostnatal exposureAcetaminophen exposureAge 11 yearsHigh riskDanish National Birth CohortBehavioral problemsNational Birth CohortTotal difficultiesChild-reported scoresMother-child pairsAcetaminophen usePrenatal exposureRisk ratioBirth cohortSDQ scoresCumulative weeksYoung childrenAssociationExposurePrenatalChildrenBehavioral outcomesOutcomesEarly adolescence
2017
Test-retest reliability and validity of a frustration paradigm and irritability measures
Tseng WL, Moroney E, Machlin L, Roberson-Nay R, Hettema JM, Carney D, Stoddard J, Towbin KA, Pine DS, Leibenluft E, Brotman MA. Test-retest reliability and validity of a frustration paradigm and irritability measures. Journal Of Affective Disorders 2017, 212: 38-45. PMID: 28135689, PMCID: PMC8049456, DOI: 10.1016/j.jad.2017.01.024.Peer-Reviewed Original ResearchConceptsTest-retest reliabilityParent-reported irritabilityIrritability measuresGood test-retest reliabilityNegative affectIrritability ScaleValidity of assessmentsBehavioral paradigmsChild irritabilityTreatment researchGeneral population sampleConvergent validityExcellent test-retest reliabilityModest supportConstruct validityTaskParticipantsIrritabilityParadigmIntraclass correlation
2012
Effects of autistic traits on social and school adjustment in children and adolescents: The moderating roles of age and gender
Hsiao MN, Tseng WL, Huang HY, Gau SS. Effects of autistic traits on social and school adjustment in children and adolescents: The moderating roles of age and gender. Research In Developmental Disabilities 2012, 34: 254-265. PMID: 22960068, DOI: 10.1016/j.ridd.2012.08.001.Peer-Reviewed Original ResearchConceptsAutistic-like social deficitsSocial Responsiveness ScaleNegative peer relationshipsSocial deficitsRole of ageSocial adjustmentPeer relationshipsNegative school attitudesSocial Adjustment InventoryDomains of adjustmentProblematic peer interactionsSocial adjustment problemsPoor academic performanceAutistic traitsSchool adjustmentResponsiveness ScaleAdjustment InventorySchool maladjustmentSchool attitudesAdjustment problemsBehavioral problemsPeer interactionsAcademic performanceGrade 8Child's age
2007
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on Once-Daily Atomoxetine Hydrochloride in Taiwanese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Gau SS, Huang YS, Soong WT, Chou MC, Chou WJ, Shang CY, Tseng WL, Allen AJ, Lee P. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on Once-Daily Atomoxetine Hydrochloride in Taiwanese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Journal Of Child And Adolescent Psychopharmacology 2007, 17: 447-460. PMID: 17822340, DOI: 10.1089/cap.2006.0091.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdrenergic Uptake InhibitorsAppetiteAtomoxetine HydrochlorideAttention Deficit Disorder with HyperactivityChildDouble-Blind MethodDrug Administration ScheduleFacultyFemaleHumansMaleNauseaParentsPropylaminesPsychiatric Status Rating ScalesSeverity of Illness IndexTaiwanTreatment OutcomeConceptsAttention-deficit/hyperactivity disorderPrimary efficacy measureEfficacy measuresDaily atomoxetineAdverse eventsADHD Rating Scale-IV-Parent VersionDrug-related serious adverse eventsHyperactivity disorderSecondary efficacy measuresSerious adverse eventsClinical Global ImpressionCarried-forward approachEnd of studyTreatment effect sizeAtomoxetine groupPlacebo groupTreat basisPediatric patientsGlobal ImpressionSafe treatmentClinical trialsInvestigator AdministeredEdition criteriaTreatment groupsMental disorders